Ladenson P W, Singer P A, Ain K B, Bagchi N, Bigos S T, Levy E G, Smith S A, Daniels G H, Cohen H D
The Johns Hopkins University School of Medicine, Baltimore, MD 21287-0003, USA.
Arch Intern Med. 2000 Jun 12;160(11):1573-5. doi: 10.1001/archinte.160.11.1573.
To define the optimal approach to identify patients with thyroid dysfunction.
The 8-member Standards of Care Committee of the American Thyroid Association prepared a draft, which was reviewed by the association's 780 members, 50 of whom responded with suggested revisions.
Relevant published studies were identified through MEDLINE and the association membership's personal resources.
Consensus was reached at group meetings. The first draft was prepared by a single author (P.W.L.) after group discussion. Suggested revisions were incorporated after consideration by the committee.
The American Thyroid Association recommends that adults be screened for thyroid dysfunction by measurement of the serum thyrotropin concentration, beginning at age 35 years and every 5 years thereafter. The indication for screening is particularly compelling in women, but it can also be justified in men as a relatively cost-effective measure in the context of the periodic health examination. Individuals with symptoms and signs potentially attributable to thyroid dysfunction and those with risk factors for its development may require more frequent serum thyrotropin testing.
确定识别甲状腺功能障碍患者的最佳方法。
美国甲状腺协会的8名护理标准委员会成员起草了一份草案,该协会的780名成员对其进行了审阅,其中50人回复了建议的修订内容。
通过医学文献数据库(MEDLINE)和协会成员的个人资源确定了相关的已发表研究。
在小组会议上达成了共识。初稿由一位作者(P.W.L.)在小组讨论后撰写。委员会在考虑后纳入了建议的修订内容。
美国甲状腺协会建议,成年人应从35岁开始,每5年通过检测血清促甲状腺激素浓度来筛查甲状腺功能障碍。筛查的指征在女性中尤为迫切,但在男性中,作为定期健康检查中的一项相对经济有效的措施,也有其合理性。有潜在归因于甲状腺功能障碍的症状和体征的个体以及有甲状腺功能障碍发生风险因素的个体可能需要更频繁地检测血清促甲状腺激素。